Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Empagliflozin effects on iron metabolism as a possible mechanism for improved clinical outcomes in non-diabetic patients with systolic heart failure ; volume:2 ; number:11 ; day:26 ; month:10 ; year:2023 ; pages:1032-1043 ; date:11.2023
Nature cardiovascular research ; 2, Heft 11 (26.10.2023), 1032-1043, 11.2023
- Creator
-
Angermann, Christiane E.
Santos-Gallego, Carlos G.
Requena-Ibanez, Juan Antonio
Sehner, Susanne
Zeller, Tanja
Gerhardt, Louisa Maria Sophie
Maack, Christoph
Sanz, Javier
Frantz, Stefan
Fuster, Valentin
Ertl, Georg
Badimon, Juan J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s44161-023-00352-5
- URN
-
urn:nbn:de:101:1-2024012915035880399001
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:35 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Angermann, Christiane E.
- Santos-Gallego, Carlos G.
- Requena-Ibanez, Juan Antonio
- Sehner, Susanne
- Zeller, Tanja
- Gerhardt, Louisa Maria Sophie
- Maack, Christoph
- Sanz, Javier
- Frantz, Stefan
- Fuster, Valentin
- Ertl, Georg
- Badimon, Juan J.
- SpringerLink (Online service)
Other Objects (12)
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats
Carbapenem-resistant Acinetobacter baumannii infections among diabetic and non-diabetic patients and possible effective combination treatments
Differential expression of micro RNA-29 family in non-diabetic adults of diabetic and non-diabetic parents
Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients
Bacterial vaginal infections in diabetic and non-diabetic women
Cerebral hemodynamics among non-diabetic hemodialysis patients
Transcriptomic and proteomic pathways of diabetic and non-diabetic mitochondrial transplantation
Pediatric non-diabetic ketoacidosis: a case-series report
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
Metabolic Effect of High Environmental Temperature on Non-Diabetic and Diabetic Rats
Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations
Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats
Carbapenem-resistant Acinetobacter baumannii infections among diabetic and non-diabetic patients and possible effective combination treatments
Differential expression of micro RNA-29 family in non-diabetic adults of diabetic and non-diabetic parents
Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients
Bacterial vaginal infections in diabetic and non-diabetic women
Cerebral hemodynamics among non-diabetic hemodialysis patients
Transcriptomic and proteomic pathways of diabetic and non-diabetic mitochondrial transplantation
Pediatric non-diabetic ketoacidosis: a case-series report
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
Metabolic Effect of High Environmental Temperature on Non-Diabetic and Diabetic Rats
Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations
Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats
Carbapenem-resistant Acinetobacter baumannii infections among diabetic and non-diabetic patients and possible effective combination treatments
Differential expression of micro RNA-29 family in non-diabetic adults of diabetic and non-diabetic parents
Empagliflozin and dapagliflozin decreased atrial monoamine oxidase expression and alleviated oxidative stress in overweight non-diabetic cardiac patients
Bacterial vaginal infections in diabetic and non-diabetic women
Cerebral hemodynamics among non-diabetic hemodialysis patients
Transcriptomic and proteomic pathways of diabetic and non-diabetic mitochondrial transplantation
Pediatric non-diabetic ketoacidosis: a case-series report
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
Metabolic Effect of High Environmental Temperature on Non-Diabetic and Diabetic Rats
Circulating metabolic biomarkers of renal function in diabetic and non-diabetic populations